TELA Bio (TELA) EBIAT (2018 - 2025)
Historic EBIAT for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to -$8.6 million.
- Bio's EBIAT rose 1705.55% to -$8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.0 million, marking a year-over-year increase of 608.1%. This contributed to the annual value of -$37.8 million for FY2024, which is 1890.75% up from last year.
- Per Bio's latest filing, its EBIAT stood at -$8.6 million for Q3 2025, which was up 1705.55% from -$9.9 million recorded in Q2 2025.
- Bio's 5-year EBIAT high stood at -$5.7 million for Q1 2024, and its period low was -$12.9 million during Q4 2023.
- Its 5-year average for EBIAT is -$10.1 million, with a median of -$10.4 million in 2024.
- Per our database at Business Quant, Bio's EBIAT surged by 5293.09% in 2024 and then crashed by 9897.54% in 2025.
- Bio's EBIAT (Quarter) stood at -$8.6 million in 2021, then fell by 15.78% to -$10.0 million in 2022, then dropped by 29.17% to -$12.9 million in 2023, then rose by 28.56% to -$9.2 million in 2024, then rose by 6.57% to -$8.6 million in 2025.
- Its last three reported values are -$8.6 million in Q3 2025, -$9.9 million for Q2 2025, and -$11.3 million during Q1 2025.